bcma-specific car-t cells for r/r multiple myeloma
Published 4 years ago • 53 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
1:53
phe885, a t-charge manufactured bcma-directed car-t therapy in r/r myeloma
-
0:53
incorporating bcma-targeted car-t therapy in the frontline treatment of multiple myeloma
-
3:31
phe885, a novel bcma-directed car-t therapy for patients with r/r multiple myeloma
-
5:00
meta-analysis: anti-bcma car-t in r/r multiple myeloma
-
1:45
anti-bcma car t-cell therapy for multiple myeloma: latest studies
-
4:51
promising bcma-targeting car-t cells for relapsed myeloma
-
11:40
immunotherapy of myeloma: bcma/slamf7 car t-cells & bites
-
2:14
a new classification for identifying high-risk myeloma based on cytogenetic abnormalities
-
2:05
novel car-t constructs being explored in myeloma: t-charge platform
-
0:58
novel car-t constructs emerging in multiple myeloma for patients who experience loss of bcma
-
2:10
mechanisms of resistance to car t-cells in myeloma & future considerations
-
1:31
integrating bcma-directed bispecifics and car-t into the myeloma treatment landscape
-
1:27
early results of phe885, a novel bcma-directed car-t therapy for the treatment of r/r mm
-
1:59
investigating the mechanisms of initial & acquired resistance to bcma car-t therapy in myeloma
-
2:27
bms-986393, a novel anti-gprc5d car-t cell therapy, in multiple myeloma
-
1:13
car t-cells: targeting bcma
-
3:35
phase i/ii trial of p-bcma-101 car-t cell therapy in r/r myeloma
-
0:59
phase i study of cart-ddbcma in r/r multiple myeloma
-
5:56
advances in car-t therapy for r/r multiple myeloma: ide-cel & cilta-cel